About Parimer
OUR HISTORY
Parimer Scientific is an independent, American-owned, and operated private scientific service laboratory that was started in 2018. Today, Parimer is best classified as a Drug Substance CDMO that supports dozens of clients in their efforts to get new molecules and treatments to those in need.
Parimer has no shareholders, private equity interests, or other profit-driven parties beyond the chemists and engineers employed in the company's operations. This organizational structure allows Parimer to remain highly competitive against more corporate and executive-heavy competitors.
Our Leadership Team
Richard T. Pace, PhD
Owner and Principal Scientist
At Parimer, Dr. Pace serves as the principal engineer and principal scientist in issues of biomedical chemistry. He stays current on scientific developments as an Adjunct Professor of Bioengineering at Clemson University.
Stephen Lee, MS
Research Manager
Stephen manages contract research operations. His knowledge and experience with industrial chemistry along with his Master's Degree in Chemistry from Georgia Tech makes him a valuable leader in Parimer's Sucess. Stephen is also an Adjunct Instructor of Chemistry at Greenville Technical College.
M. Victoria Bobo, PhD
Senior Scientist & Quality Director
Dr. Bobo serves as the head of Parimer's Quality efforts. She directly oversees our regulatory compliance concerns including FDA, ISO, and Board of Pharmacy Compliance. Her research into advanced catalytic chemistry culminated with a doctorate degree in Chemistry from USC.
​
Ladson DuBose, BS
Research Scientist
Ladson conducts biological testing for Parimer’s projects and assists with research and development operations. He researched stem cell replacement in bovine intervertebral discs as an undergraduate at Clemson University where he earned a BS degree in Biology.
